Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Bad science & bogus treatments

Another case of HIV cure hype-atitis

Editor's pick
HIV Cure
13 November 2019
Treatment simplification strategies

Jitters Over New Two-Drug HIV Regimens

Editor's pick
Medscape (requires free registration)
12 November 2019
HIV treatment

Biktarvy Maintains High Efficacy for Three Years in Clinical Trials

Editor's pick
POZ
11 November 2019
Weight gain & lipodystrophy

Dolutegravir and raltegravir cause changes to fat cells

News
11 November 2019
Bad science & bogus treatments

Gene Therapy and 'Cure': Tone It Down!

Editor's pick
Science
11 November 2019
Side effects

Weight gain after switching to integrase inhibitor treatment is small in Dutch and Swiss cohorts

News
11 November 2019
Treatment guidelines

New European HIV guidelines cater for multiple needs

News
10 November 2019
Side effects

ADVANCE study shows high frequency of major weight gain in women receiving dolutegravir with TAF

News
8 November 2019
Side effects

Weight gain on HIV treatment: drug combinations, not single drugs, need to be focus of quest for cause

News
8 November 2019
Bad science & bogus treatments

Misleading Ads About PrEP Are Threatening Progress to End the HIV Epidemic. They Must Be Removed.

Editor's pick
TheBodyPro
7 November 2019
Resistance

FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations

Editor's pick
Food & Drug Administration
6 November 2019
HIV treatment

Learning the Names of HIV Drugs Is Horribly Difficult — Here’s Why

Editor's pick
HIV and ID Observations
4 November 2019
Bone & joint problems

Switching from TDF to TAF associated with improvements in bone mineral density in people over 60

News
4 November 2019
Women

Women and HIV in the United Kingdom

Editor's pick
Public Health England
2 November 2019
Side effects

Updated Labeling for Efavirenz-Containing Products Warns of Possible Late-Onset Neurotoxicity

Editor's pick
Monthly Prescribing Reference
31 October 2019
Starting treatment

Weight gain on HIV treatment: more common with newer drugs, low CD4 counts

News
31 October 2019
Cardiovascular disease

Delaying HIV Treatment Linked to Stiffened Blood Vessels

Editor's pick
POZ
30 October 2019
Reproductive health

Women with HIV not at higher risk of blood pressure disorders in pregnancy

News
30 October 2019
Treatment interruptions

Pausing the pills: attitudes to treatment interruption

Editor's pick
HIV Cure
28 October 2019
Adherence

Medication lockers help Miami's homeless living with HIV

Editor's pick
Associated Press
28 October 2019
Kidney problems

Chronic kidney disease increases risk of numerous illnesses and death for people with HIV

News
23 October 2019
Low CD4 count

Two-Drug HIV Regimen Works Well Except in People With Low CD4 Count, Study Finds

Editor's pick
TheBodyPro
22 October 2019
Neurological & cognitive problems

Prevalence of self-reported neurocognitive impairment falls among people with HIV in Switzerland

News
22 October 2019
TB treatment

Dolutegravir-based regimen safe and effective for people taking rifampicin for TB

News
20 October 2019